EMCURE - Swing Trade Analysis with AI Signals
Last Updated Time : 20 Dec 25, 07:01 am
Back to Swing Trade ListSwing Trade Rating: 3.4
| Stock Code | EMCURE | Market Cap | 26,224 Cr. | Current Price | 1,383 ₹ | High / Low | 1,525 ₹ |
| Stock P/E | 60.6 | Book Value | 170 ₹ | Dividend Yield | 0.22 % | ROCE | 13.5 % |
| ROE | 11.6 % | Face Value | 10.0 ₹ | DMA 50 | 1,383 ₹ | DMA 200 | 1,332 ₹ |
| Chg in FII Hold | 0.43 % | Chg in DII Hold | 1.52 % | PAT Qtr | 118 Cr. | PAT Prev Qtr | 125 Cr. |
| RSI | 49.2 | MACD | 5.76 | Volume | 35,654 | Avg Vol 1Wk | 81,584 |
| Low price | 889 ₹ | High price | 1,525 ₹ | PEG Ratio | -4.47 | Debt to equity | 0.50 |
| 52w Index | 77.8 % | Qtr Profit Var | 35.3 % | EPS | 22.7 ₹ | Industry PE | 30.6 |
📊 EMCURE shows moderate potential for swing trading. Current price (₹1,383) is aligned with the 50 DMA (₹1,383) and above the 200 DMA (₹1,332), reflecting neutral-to-positive momentum. RSI at 49.2 is neutral, while MACD (5.76) indicates mild bullish sentiment. Fundamentals are decent with ROCE (13.5%) and ROE (11.6%), though debt-to-equity at 0.50 is relatively high. Valuation is stretched with a P/E of 60.6 compared to industry average of 30.6. Optimal entry would be near ₹1,350–₹1,370 on dips. If already holding, exit near ₹1,480–₹1,500 resistance unless momentum strengthens further.
✅ Positive
- 📈 ROCE (13.5%) and ROE (11.6%) show moderate efficiency
- 📊 EPS at ₹22.7 supports valuation strength
- 📈 Quarterly PAT remains strong at ₹118 Cr. despite slight decline
- 📊 Institutional interest: FII +0.43%, DII +1.52%
- 📉 Debt-to-equity at 0.50 is manageable though higher than peers
⚠️ Limitation
- 📉 Current price only at par with 50 DMA, showing limited momentum
- 📊 RSI neutral, not strongly bullish
- 📉 High P/E ratio (60.6 vs industry 30.6)
- ⚠️ PEG ratio negative (-4.47), limiting growth valuation
- 📉 Trading volume below weekly average
🚨 Company Negative News
- 📉 PAT declined slightly from ₹125 Cr. to ₹118 Cr.
- ⚠️ Debt-to-equity relatively high at 0.50
🌟 Company Positive News
- 📈 Quarterly profit variation shows growth (+35.3%)
- 📊 Institutional investors increasing stake
- 📉 Debt remains manageable despite leverage
🏭 Industry
- 📊 Industry P/E at 30.6, much lower than company’s 60.6
- 📈 Pharma sector has long-term growth potential with global demand tailwinds
📌 Conclusion
⚖️ EMCURE is a fair swing trade candidate with decent fundamentals but stretched valuations and neutral technicals. Entry is favorable near ₹1,350–₹1,370 on dips. For existing holders, exit near ₹1,480–₹1,500 resistance is advisable unless RSI and MACD show stronger recovery.
Would you like me to also outline EMCURE’s medium-term support and resistance zones so you can track swing opportunities beyond the immediate levels?
Back to Swing Trade ListNIFTY 50 - Today Top Swing Trade Stock Picks
NEXT 50 - Today Top Swing Trade Stock Picks
MIDCAP - Today Top Swing Trade Stock Picks
SMALLCAP - Today Top Swing Trade Stock Picks